Liothyronine Sodium Tablet
Product Images NDC 50090-5586

2 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Liothyronine Sodium (NDC 50090-5586). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (15ed7dff A305 4a76 Aedd F932fa27b36c 01)

Image (15ed7dff A305 4a76 Aedd F932fa27b36c 01)
Chemical structure of Liothyronine sodium showing molecular composition C15H11I3NNaO4 and molecular weight 672.96. The diagram includes aromatic rings with iodine and hydroxyl substituents, a sodium carboxylate group, and an amine group attached to the carbon skeleton.*
FDA Label Image

Label Image (Lbl500905586)

Label Image (Lbl500905586)
Liothyronine sodium 5 mcg oral tablets, packaged in a bottle of 100 tablets. The label displays the NDC 50090-5586-0 and lists A-S Medication Solutions as the labeler based in Libertyville, Illinois. Storage instructions indicate to keep the product between 59 to 86 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.